ArticleThe American journal of case reports2025
Co-Occurrence of Systemic Sclerosis, Lupus, and Celiac Disease in Multiple Autoimmune Syndrome: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Multiple autoimmune syndromes are caused by immune dysregulation pathways and shared genetic polymorphisms, resulting in the coexistence of multiple autoimmune disorders. Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are connective tissue diseases with distinct pathogenesis. Celiac disease (CD) is an immune-mediated small intestine pathology. Previous case reports have documented the coexistence of SLE and CD, SSc and CD, and SSc and SLE (overlap syndrome). CASE REPORT A 21-year-old woman with juvenile SSc and interstitial lung disease was admitted with fever, cough, and ongoing lower abdominal pain, diarrhea, and weight loss for the previous 3 months. Laboratory investigations revealed leukopenia, normocytic normochromic anemia, and thrombocytopenia, with positive antinuclear antibody and anti-double-stranded DNA. SLE was diagnosed, and the patient was started on a steroid and hydroxychloroquine. Celiac serology was ordered, followed by an upper gastrointestinal endoscopy, with biopsy. The results of both tests indicated CD. The patient was advised to follow a gluten-free diet and was started on hydroxychloroquine, mycophenolate mofetil, and prednisolone. CONCLUSIONS Our patient's presentation of CD and SLE occurring 9 years after SSc onset is unique. Individuals with one autoimmune disease have approximately a 25% chance of developing another. Limited case reports discuss CD in patients with SSc and the association between CD and SLE. To the best of our knowledge, no prior reports documented the coexistence of SSc, SLE, and CD. This case report underscores the importance of investigating autoimmune syndromes based on clinical presentation, as rare associations can occur.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.